Jakarta- AdMedika has held its Annual General Meeting of Shareholders (AGM) for the fiscal year 2022, today Wednesday, (14/6).

The implementation of the AGMS Agenda is a form of AdMedika's accountability for the Company throughout 2022. The event was chaired by AdMedika President Commissioner Jati Widagdo and took place in a hybrid manner, namely offline and online. The offline event took place at Telkom Landmark Tower Lt. 41 which was attended by AdMedika Shareholders, the Board of Commissioners, AdMedika Directors and attended by Notary.

AdMedika Shareholders have approved and accepted the annual report submitted by the President Director of AdMedika on behalf of AdMedika's board of directors, regarding the state and course of the Company as well as the Supervisory Task Report by the Board of Commissioners for the fiscal year 2022, and determined that there are changes in the Company's management for the board of commissioners, and there are no changes for the board of directors.

The composition of AdMedika's Board of Commissioners and Board of Directors after the AGMS for the financial year 2022, is as follows:

Board of Commissioners

1. President Commissioner: Jati Widagdo

2. Commissioner : Rachmat Mulyana

3. Commissioner : Sendy A Kamesvara

Board of Directors

1. President Director : Dwi Sulistiani

2. Director : Dian Prambini

3. Director : Ace

Congratulations and success in continuing your duties as commissioners and directors.